Read + Share
Ameratunga M, Brana I, Bono P, Postel-Vinay S, et al. First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients
with selected solid tumours. Br J Cancer 2020;123:1730-1736.
PMID: 32989226
|
 |
|
Ameratunga M, Brana I, Bono P, Postel-Vinay S, et al. First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients
with selected solid tumours. Br J Cancer 2020;123:1730-1736.
PMID: 32989226
|
|
|
|